COPENHAGEN, Denmark, January 19, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 7, 2026, under which the Company will repurchase shares for an amount up to DKK 150 million in the period from January 7, 2026 to February 13, 2026. The program is executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.
Since the last announcement of transactions on January 12, 2026, the following transactions have been made by Nordea on behalf of Bavarian Nordic:
Number of sharesAverage purchase price, DKKTransaction value, DKKAccumulated until January 12, 202680,895198.6816,072,325January 12, 2026 7,000198.84 1,391,904January 13, 2026 25,000198.64 4,966,045January 14, 2026 5,957200.04 1,191,660January 15, 2026 55,000198.53 10,919,222January 16, 2026 16,045198.58 3,186,277Accumulated under the program189,897198.6737,727,433
The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.
Following these transactions, Bavarian Nordic holds a total of 1,156,742 treasury shares, corresponding to 1.46% of the Company’s share capital.
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements.
